查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806504

全球 IVF 市場（按產品類型、胚胎來源、程序類型、應用和最終用戶）：預測（2025-2030 年）

In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 IVF 市場規模到 2024 年將達到 121.7 億美元，到 2025 年將達到 134 億美元，到 2030 年將達到 221 億美元，複合年成長率為 10.45%。

主要市場統計數據
預測年份（2024年） 121.7億美元
基準年（2025年） 134億美元
預測年份（2030年） 221億美元
複合年成長率（%） 10.45%

新興趨勢和未滿足的需求推動體外受精領域的創新、可及性和以患者為中心的解決方案

體外受精（IVF）領域已從最初的實驗階段發展成為生殖醫學的基石，致力於應對複雜的生物學、倫理學和經濟學挑戰。受孕延遲和不孕症上升等人口趨勢變化的推動，該市場對先進實驗室能力和個人化治療通訊協定的需求日益成長。胚胎培養和冷凍保存的技術創新正在提高成功率，而不斷發展的法律規範則持續影響醫療服務的可近性和報銷途徑。患者的期望也在不斷變化。如今的準父母需要透明的治療結果指標、微創治療方法以及能夠即時更新治療過程的數位互動工具。

技術突破與以患者為中心的策略相結合，正在重新定義全球 IVF 成功指標和獲取模式

在實驗室自動化、數位監控和精準醫療領域取得突破的推動下，試管嬰兒 (IVF) 產業正在經歷變革時期。互聯平台與雲端基礎資料管理的整合，使得遠端監控孵化器和預測胚胎活力的分析儀錶板成為可能。此外，人工智慧演算法正在開創預測成功率模型的新範式，增強胚胎學家對胚胎進行分級的專業知識。隨著這些技術進步，醫療服務提供者正在採用以患者為中心的策略，提供遠距健康諮詢、個人化卵巢刺激方案和客製化的基因分析服務。

預計 2025 年的關稅調整將促使美國IVF 供應商重組其供應鏈、成本結構和戰略計劃

2025年，美國新近頒布的針對進口培養基套件、一次性用品和專用檢測設備的關稅，為試管嬰兒（IVF）提供者帶來了巨大的阻力。這些調整擾亂了長期存在的供應鏈，促使供應商重新談判契約，並促使企業投資於國內冷凍保存培養基和顯微操作儀器的生產設施。隨著進口成本的上升，診所面臨著要麼消化增加的成本，要麼透過調整服務費用轉嫁成本的壓力，這加劇了對成本效益和臨床差異化服務的競爭。

對產品供應、胚胎採購選項、手術方式、臨床應用和最終用戶管道的全面分析突出了機會

從產品類型來看，培養基（包括冷凍保存培養基、胚胎培養製劑、卵子處理液和精子處理試劑）由於直接影響實驗室結果，繼續成為研發投資的重點。同時，微流體晶片和一次性移液器等一次性設備和配件因其能夠提高操作無菌性並最大限度地降低交叉污染風險而備受關注。對於尋求操作一致性的實驗室而言，諸如隔振台、低溫系統、氣體分析儀、高級成像平台、培養箱、體外受精櫃、雷射系統、顯微操作套件、顯微鏡、抽吸泵、精子分析儀、分離器和目擊追蹤解決方案等設備類別仍然至關重要。

美洲、歐洲、中東和非洲地區以及亞太地區不同的區域動態和法規環境推動了獨特的成長模式和投資重點

美洲地區展現出成熟的市場特徵，擁有完善的報銷途徑、對監管協調的承諾以及對個人化生育治療解決方案的關注。尤其是美國的診所，它們正在利用遠端醫療和直接面對消費者的基因檢測來差異化其服務，而加拿大的醫療服務提供者則受益於公共資助模式。相較之下，歐洲、中東和非洲地區的特點是各國法規紛繁複雜，從西歐嚴格的胚胎檢測法到中東對不孕症治療旅遊中心日益成長的投資，再到一些非洲國家尚處於服務發展的早期階段，不一而足。該地區的醫療保健提供者必須應對複雜的合規環境，同時充分利用跨境患者流量。

領先產業參與者的策略定位和創新組合揭示了體外受精領域的競爭進步和夥伴關係趨勢

體外受精 (IVF) 市場的主要企業正透過策略性地多元化產品平臺和擴展服務網路來脫穎而出。跨國生命科學公司正在透過先進的冷凍保存解決方案和人工智慧胚胎選擇平台來擴充其產品組合，而生殖醫學專家則繼續投資於顯微操作技術和照護現場診斷檢測。一些主要企業正在收購區域性連鎖實驗室，以獲得直接獲取臨床工作流程和檢體量的管道，並強化其端到端服務模式。

為產業領導者提供可行的策略，以最佳化營運、促進合作並利用新興的 IVF機會

產業領導者應優先考慮供應鏈多元化，與國內培養基和設備夥伴關係合作，以減輕關稅波動的影響。投資用於胚胎活力評估和實驗室工作流程自動化的人工智慧，可以顯著提高臨床效率，縮短懷孕時間。擴展遠端醫療和遠端監控能力，可以滿足患者對便利性的需求，並增強整個治療週期的連續性。

一個強大的多階段研究框架，整合了主要專家參與、二手資料檢驗和定量情境分析

研究途徑採用多階段框架，首先對50多位生育專家、胚胎學家、實驗室主任和設備製造商進行深入訪談，以了解他們對技術應用和臨床挑戰的第一手觀點。之後，研究人員進行了二次研究，全面回顧了同行評審期刊、監管文件、專利資料庫和已發表的臨床指南，檢驗並強化定性見解。

技術進步、監管影響和市場動態的綜合展現了全球 IVF 的發展路徑和未來前景

試管嬰兒（IVF）產業整體呈現了技術創新、監管格局演變以及患者期望之間複雜的相互作用，這些因素共同塑造著其未來的發展軌跡。先進的培養基和冷凍保存技術正在為實驗室性能樹立新的標桿，而人工智慧和數位健康平台則正在重新定義患者參與和臨床決策支援。美國關稅政策的連鎖反應正在推動供應鏈重組，鼓勵國內生產，並凸顯了韌性和適應性的重要性。

目錄

第1章 引言

第2章 分析方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 試管嬰兒實驗室擴大使用人工智慧胚胎選擇和縮時攝影來最佳化植入率。
  • 受職場不孕不育福利和社會趨勢的推動，選擇性卵子冷凍服務蓬勃發展
  • 為希望在治療前保留生育能力的癌症患者擴大菲達起司項目
  • 可攜式照護現場嬰兒系統的出現，使新興市場能夠實現分散式不孕症治療
  • 擴大採用 PGT-A 檢測服務來減少基因異常並改善治療效果
  • 整合遠端醫療和數位健康平台，實現遠距IVF諮詢和監測
  • 加強生育診所和基因檢測實驗室之間的合作，以進行個體化胚胎評估

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章：美國關稅的累積影響（2025年）

第 8 章 IVF 市場：依產品分類

  • 培養基
    • 冷凍保存培養基
    • 胚胎培養基
    • 卵子處理介質
    • 精子處理培養基
  • 一次性設備和配件
  • 裝置
    • 防震台
    • 低溫保存系統
    • 氣體分析儀
    • 影像分析系統
    • 培養箱
    • 試管嬰兒櫃
    • 雷射系統
    • 微作業系統
    • 顯微鏡
    • 卵子吸泵
    • 精子分析系統
    • 精子分離裝置
    • 檢體管理系統

第9章 IVF市場：依胚胎來源

  • 新捐款者
  • 新的非捐贈者
  • 凍結捐贈者
  • 冷凍非捐贈者

第 10 章體外受精市場（依程序類型）

  • 輔助孵化
  • 常規試管嬰兒
  • 冷凍胚胎移植（FET）
  • 配子輸卵管植入（GIFT）
  • 卵細胞質內單一精蟲顯微注射術（ICSI）
  • 受精卵輸卵管內移植（ZIFT）

第 11 章 IVF 市場：依應用

  • 女性不孕症
    • 子宮內膜異位症
    • 排卵障礙
    • 輸卵管因素不孕
    • 不明原因的不孕症
  • 男性不孕
    • 精子形態異常
    • 少精子症
    • 精子活力低

第 12 章：體外受精市場（依最終用戶）

  • 門診手術中心
  • 不孕不育診所
  • 醫院

13. 美國試管嬰兒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲試管嬰兒市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15. 亞太地區試管嬰兒市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 市場佔有率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • Carl Zeiss AG
    • Cook Medical Inc.
    • CooperSurgical Inc.
    • Corning incorporated
    • Ferring BV
    • Esco micro pte. Ltd.
    • FertiPro NV
    • Genea Biomedx Pty Ltd.
    • Hamilton Thorne, Inc.
    • INVO Bioscience, Inc.
    • IVFtech ApS
    • Kitazato Corporation
    • Laboratoire CCD
    • Merck KGaA
    • Nidacon International AB
    • Nikon Corporation
    • Olympus Corporation
    • Thermo Fisher Scientific Inc.
    • Vitrolife AB
    • Meiji Techno Co., Ltd.

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-43127F7279FE

The In-Vitro Fertilization Market was valued at USD 12.17 billion in 2024 and is projected to grow to USD 13.40 billion in 2025, with a CAGR of 10.45%, reaching USD 22.10 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 12.17 billion
Estimated Year [2025] USD 13.40 billion
Forecast Year [2030] USD 22.10 billion
CAGR (%) 10.45%

Emerging Trends and Unmet Needs Propel Innovation, Accessibility, and Patient-Centric Solutions Across the In-Vitro Fertilization Landscape

The in-vitro fertilization discipline has emerged from its experimental origins to become a cornerstone of reproductive health, addressing complex biological, ethical, and economic challenges. Driven by shifting demographic trends such as delayed parenthood and rising infertility rates, the market is witnessing heightened demand for advanced laboratory capabilities and personalized treatment protocols. Technological innovations in embryo culture and cryopreservation have expanded success rates, while evolving regulatory frameworks continue to shape accessibility and reimbursement pathways. Patient expectations are also evolving; today's prospective parents seek transparent outcome metrics, minimally invasive procedures, and digital engagement tools that deliver real-time updates on their treatment journey.

Simultaneously, the convergence of data analytics and artificial intelligence is revolutionizing embryo selection and laboratory workflow optimization, reducing time to pregnancy and improving consistency of outcomes. As competition intensifies among clinics, device manufacturers, and service providers, strategic collaboration and vertical integration are gaining traction as means to control quality and manage costs. In this milieu, ethical considerations surrounding genetic testing and embryo manipulation further underscore the need for robust governance and practitioner training. Altogether, these dynamics set the stage for an era of innovation where patient-centric solutions, operational excellence, and scientific rigor will define leadership in the in-vitro fertilization arena.

Technological Breakthroughs Combined with Patient-Centric Strategies Are Redefining Success Metrics and Access Models in In-Vitro Fertilization Globally

The in-vitro fertilization sector is undergoing a transformative shift fueled by breakthroughs in laboratory automation, digital monitoring, and precision medicine. Integration of connectivity platforms and cloud-based data management is enabling remote monitoring of incubators and analytic dashboards that forecast embryo viability. Furthermore, artificial intelligence algorithms are augmenting embryologists' expertise in grading embryos, ushering in a new paradigm of predictive success modeling. Alongside these technological advances, providers are embracing patient-centric strategies that offer telehealth consultations, personalized ovarian stimulation regimens, and tailored genetic profiling services.

In parallel, the industry is witnessing a consolidation wave among clinics and laboratory suppliers, driven by the pursuit of scale efficiencies and broader geographic coverage. Mergers and strategic alliances are creating regional and global networks that facilitate standardized protocols and pooled resources for research and development. Meanwhile, emerging markets in Asia and South America are recalibrating their regulatory and reimbursement policies to encourage domestic investment and medical tourism. As demand diversifies-with growing awareness of male factor infertility and the rise of fertility preservation among cancer survivors-stakeholders are called upon to innovate across both product and service dimensions, ensuring that clinical excellence and equitable access advance hand in hand.

Projected Tariff Adjustments in 2025 Are Reshaping Supply Chains, Cost Structures, and Strategic Planning for U.S. In-Vitro Fertilization Providers

In 2025, newly enacted U.S. tariffs on imported culture media kits, disposable devices, and specialized laboratory equipment introduced significant headwinds for in-vitro fertilization providers. These adjustments disrupted long-standing supply chains, prompted renegotiation of vendor contracts, and catalyzed investment in domestic manufacturing facilities for cryopreservation media and micromanipulation instruments. As import costs rose, clinics faced pressure to absorb incremental expenses or pass them along through adjusted service fees, intensifying competition on cost efficiency and clinical differentiation.

To mitigate these challenges, many providers established strategic partnerships with local suppliers capable of producing laser systems, incubators, and anti-vibration tables at scale. Others accelerated adoption of modular laboratory designs that allow equipment sharing across service lines, optimizing utilization and reducing capital intensity. Moreover, the tariff environment has spurred exploration of alternate sourcing options, including collaborative R&D agreements with regional biotechnology firms. While these shifts initially introduced complexity, they ultimately fostered supply chain resilience, incentivized innovation in product design, and reinforced the strategic imperative for fertility centers to adopt agile procurement and long-term strategic planning.

Comprehensive Analysis of Product Offerings, Embryo Sourcing Options, Procedure Modalities, Clinical Applications, and End-User Channels Reveals Opportunities

A nuanced examination of product categories reveals that culture media-encompassing cryopreservation media, embryo culture formulations, ovum processing solutions, and sperm processing reagents-continues to command R&D investment due to its direct impact on laboratory outcomes. Alongside this, disposable devices and accessories such as microfluidic chips and single-use transfer pipettes are gaining prominence by enhancing procedural sterility and minimizing cross-contamination risks. The equipment segment, featuring anti-vibration tables, cryosystems, gas analyzers, advanced imaging platforms, incubators, IVF cabinets, laser systems, micromanipulation suites, microscopes, aspiration pumps, sperm analyzers, separation devices, and witness tracking solutions, remains critical for laboratories seeking operational consistency.

Insights into embryo sourcing highlight a dynamic balance between fresh donor and non-donor cycles and the growing prevalence of frozen donor and non-donor transfers, driven by patient preference for cycle flexibility and single embryo transfer protocols. Procedure-type analysis underscores the sustained dominance of conventional IVF and intracytoplasmic sperm injection, complemented by rising adoption of frozen embryo transfer, assisted hatching, gamete intrafallopian transfer, and zygote intrafallopian transfer techniques. In terms of clinical application, female infertility segments such as endometriosis, ovulatory disorders, tubal factor infertility, and unexplained infertility represent the majority of treatment volumes, while male infertility categories-including abnormal sperm morphology, low sperm count, and poor motility-constitute an under-addressed opportunity. Ambulatory surgery centers, fertility clinics, and hospitals collectively define the end-user landscape, each bringing distinct procedural workflows, reimbursement frameworks, and patient engagement models.

Distinct Regional Dynamics and Regulatory Environments Drive Unique Growth Patterns and Investment Priorities Across Americas, EMEA, and Asia-Pacific

The Americas region exhibits mature market characteristics, with established reimbursement pathways, regulatory harmonization efforts, and a focus on personalized fertility solutions. U.S. clinics, in particular, are leveraging telehealth and direct-to-consumer genetic testing to differentiate their services, while Canadian providers benefit from supportive public funding models. In contrast, the Europe, Middle East & Africa corridor encompasses a mosaic of national regulations, ranging from stringent embryo testing laws in Western Europe to growing investment in fertility tourism hubs in the Middle East and nascent service development in select African nations. Providers in this region must navigate complex compliance landscapes while capitalizing on cross-border patient flows.

Asia-Pacific stands out as the fastest-growing region, propelled by government initiatives in China and India that expand fertility treatment accessibility and catalyze local manufacturing of laboratory consumables and instruments. Japan and South Korea are enhancing regulatory frameworks to incorporate advanced genetic diagnostics, and Australia and New Zealand maintain high standards for clinical accreditation and laboratory quality. Across these regions, varying demographic profiles, cultural attitudes toward fertility, and reimbursement mechanisms create differentiated growth trajectories, underscoring the necessity for targeted entry strategies and localized value propositions.

Strategic Positioning and Innovation Portfolios of Leading Industry Players Illuminate Competitive Advancements and Partnership Trends in In-Vitro Fertilization

Leading organizations in the in-vitro fertilization market are distinguishing themselves through strategic diversification of their product pipelines and expansion of service networks. Multinational life science firms have augmented their portfolios with advanced cryopreservation solutions and AI-enabled embryo selection platforms, while specialized reproductive health companies continue to invest in micromanipulation technologies and point-of-care diagnostic assays. Several key players have pursued acquisition of regional laboratory chains to secure direct access to clinic workflows and specimen volumes, reinforcing end-to-end service models.

Collaborations between equipment manufacturers and fertility providers have introduced bundled offerings that integrate hardware, consumables, and data analytics in subscription-based frameworks. Concurrently, cross-industry partnerships with genetic testing companies are facilitating seamless integration of preimplantation genetic screens. Emerging players have differentiated through agile product development cycles and localized manufacturing strategies, particularly in Asia-Pacific markets. Taken together, these competitive dynamics illustrate a landscape where technological prowess, strategic alliances, and nimble go-to-market approaches will dictate market leadership and shape the next wave of innovation.

Actionable Strategies for Industry Leaders to Optimize Operations, Foster Collaboration, and Capitalize on Emerging In-Vitro Fertilization Opportunities

Industry leaders should prioritize diversification of their supply chains by forging partnerships with domestic media and equipment suppliers to mitigate exposure to tariff fluctuations. Investing in artificial intelligence for embryo viability assessment and laboratory workflow automation can yield measurable improvements in clinical efficiency and reduce time to pregnancy. Expanding telehealth and remote monitoring capabilities will cater to patient demand for convenience and strengthen retention across treatment cycles.

Providers are encouraged to cultivate collaborative ecosystems with academic research centers and technology startups to accelerate innovation in genetic diagnostics and cryopreservation methodologies. Implementing lean manufacturing principles for consumables and adopting modular laboratory architectures can optimize capital allocation and enhance scalability. To address emerging male infertility demands, organizations should integrate targeted diagnostic services and specialized treatment protocols into their offerings. Finally, proactive monitoring of evolving regulatory requirements across key regions will enable agile compliance and future-proofed market entry strategies.

Robust Multi-Phase Research Framework Integrating Primary Expert Engagement, Secondary Data Validation, and Quantitative Scenario Analysis

The research approach employs a multi-phase framework that began with in-depth interviews conducted with over fifty fertility specialists, embryologists, laboratory directors, and equipment manufacturers to capture first-hand perspectives on technological adoption and clinical challenges. Following these discussions, secondary research encompassed a comprehensive review of peer-reviewed journals, regulatory filings, patent databases, and published clinical guidelines to validate and augment qualitative insights.

Quantitative analysis was performed through scenario modeling to assess the impact of tariff changes and regional regulatory variations on cost structures and adoption rates. Data triangulation techniques reconciled findings across primary and secondary sources, ensuring consistency and rigor. Furthermore, expert panels convened throughout the process provided iterative validation of assumptions, while internal peer review and methodological audits guaranteed transparency and reproducibility. Ethical considerations, data privacy protocols, and quality control measures underpinned each stage to deliver robust and credible market intelligence.

Synthesis of Technological Advances, Regulatory Impacts, and Market Dynamics Illustrates the Evolutionary Path and Future Outlook of Global In-Vitro Fertilization

In synthesizing the landscape of in-vitro fertilization, it becomes evident that technological innovation, regulatory evolution, and patient expectations are intricately interwoven in shaping future trajectories. Advanced culture media and cryopreservation techniques are setting new benchmarks for laboratory performance, while artificial intelligence and digital health platforms are redefining patient engagement and clinical decision support. The ripple effects of U.S. tariff policies have prompted supply chain realignment and encouraged domestic production, underscoring the importance of resilience and adaptability.

Segmentation analysis highlights the criticality of aligning product offerings with emerging procedural preferences and clinical applications, particularly in under-addressed male infertility categories. Regional insights reveal that tailored market entry strategies and local partnerships will be essential to capitalize on diverse growth drivers. Competitive dynamics among leading players demonstrate that integrated service models, strategic alliances, and agile manufacturing approaches will determine market leadership. As stakeholders navigate these converging trends, a steadfast focus on operational excellence, ethical governance, and patient-centric innovation will chart the course for sustained success in the global in-vitro fertilization sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing use of AI-driven embryo selection and time-lapse imaging in IVF labs to optimize implantation rates
  • 5.2. Rapid growth in elective egg freezing services fueled by workplace fertility benefits and social trends
  • 5.3. Expansion of oncofertility programs for cancer patients seeking fertility preservation before treatment
  • 5.4. Emergence of portable point-of-care IVF systems enabling decentralized fertility treatments in emerging markets
  • 5.5. Rising implementation of PGT-A testing services to reduce genetic abnormalities and improve outcomes
  • 5.6. Integration of telemedicine and digital health platforms for remote IVF consultations and monitoring
  • 5.7. Increasing collaboration between fertility clinics and genetic testing labs for personalized embryo assessment

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. In-Vitro Fertilization Market, by Product

  • 8.1. Introduction
  • 8.2. Culture Media
    • 8.2.1. Cryopreservation Media
    • 8.2.2. Embryo Culture Media
    • 8.2.3. Ovum Processing Media
    • 8.2.4. Sperm Processing Media
  • 8.3. Disposable Devices & accessories
  • 8.4. Equipment
    • 8.4.1. Anti-vibration Tables
    • 8.4.2. Cryosystems
    • 8.4.3. Gas Analyzers
    • 8.4.4. Imaging Systems
    • 8.4.5. Incubators
    • 8.4.6. IVF Cabinets
    • 8.4.7. Laser Systems
    • 8.4.8. Micromanipulator Systems
    • 8.4.9. Microscopes
    • 8.4.10. Ovum Aspiration Pumps
    • 8.4.11. Sperm Analyzer Systems
    • 8.4.12. Sperm Separation Devices
    • 8.4.13. Witness Systems

9. In-Vitro Fertilization Market, by Embryo Source

  • 9.1. Introduction
  • 9.2. Fresh Donor
  • 9.3. Fresh Non-donor
  • 9.4. Frozen Donor
  • 9.5. Frozen Non-donor

10. In-Vitro Fertilization Market, by Procedure Type

  • 10.1. Introduction
  • 10.2. Assisted Hatching
  • 10.3. Conventional IVF
  • 10.4. Frozen Embryo Transfer (FET)
  • 10.5. Gamete Intrafallopian Transfer (GIFT)
  • 10.6. Intracytoplasmic Sperm Injection (ICSI)
  • 10.7. Zygote Intrafallopian Transfer (ZIFT)

11. In-Vitro Fertilization Market, by Application

  • 11.1. Introduction
  • 11.2. Female Infertility
    • 11.2.1. Endometriosis
    • 11.2.2. Ovulatory Disorders
    • 11.2.3. Tubal Factor Infertility
    • 11.2.4. Unexplained Infertility
  • 11.3. Male Infertility
    • 11.3.1. Abnormal Sperm Morphology
    • 11.3.2. Low Sperm Count
    • 11.3.3. Poor Sperm Motility

12. In-Vitro Fertilization Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgery Centers
  • 12.3. Fertility Clinics
  • 12.4. Hospitals

13. Americas In-Vitro Fertilization Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa In-Vitro Fertilization Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific In-Vitro Fertilization Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Carl Zeiss AG
    • 16.3.2. Cook Medical Inc.
    • 16.3.3. CooperSurgical Inc.
    • 16.3.4. Corning incorporated
    • 16.3.5. Ferring B.V.
    • 16.3.6. Esco micro pte. Ltd.
    • 16.3.7. FertiPro N.V.
    • 16.3.8. Genea Biomedx Pty Ltd.
    • 16.3.9. Hamilton Thorne, Inc.
    • 16.3.10. INVO Bioscience, Inc.
    • 16.3.11. IVFtech ApS
    • 16.3.12. Kitazato Corporation
    • 16.3.13. Laboratoire CCD
    • 16.3.14. Merck KGaA
    • 16.3.15. Nidacon International AB
    • 16.3.16. Nikon Corporation
    • 16.3.17. Olympus Corporation
    • 16.3.18. Thermo Fisher Scientific Inc.
    • 16.3.19. Vitrolife AB
    • 16.3.20. Meiji Techno Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. IN-VITRO FERTILIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. IN-VITRO FERTILIZATION MARKET: RESEARCHAI
  • FIGURE 26. IN-VITRO FERTILIZATION MARKET: RESEARCHSTATISTICS
  • FIGURE 27. IN-VITRO FERTILIZATION MARKET: RESEARCHCONTACTS
  • FIGURE 28. IN-VITRO FERTILIZATION MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. IN-VITRO FERTILIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOPRESERVATION MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO CULTURE MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM PROCESSING MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM PROCESSING MEDIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY DISPOSABLE DEVICES & ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ANTI-VIBRATION TABLES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CRYOSYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAS ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INCUBATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY IVF CABINETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MICROSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVUM ASPIRATION PUMPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM ANALYZER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY SPERM SEPARATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY WITNESS SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN NON-DONOR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FROZEN EMBRYO TRANSFER (FET), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER (GIFT), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION (ICSI), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY OVULATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY TUBAL FACTOR INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY UNEXPLAINED INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY ABNORMAL SPERM MORPHOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY LOW SPERM COUNT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY POOR SPERM MOTILITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 151. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 152. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 153. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 154. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 155. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 169. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 171. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 172. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 173. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 174. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 175. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 176. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 177. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 179. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 181. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 182. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 187. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 188. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 189. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 190. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 191. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 192. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 193. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 194. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 195. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 200. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 201. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 203. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 205. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 206. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 207. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 208. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 209. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 210. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 211. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 212. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 213. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 218. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 219. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 220. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 221. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. ARGENTINA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 244. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 246. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 248. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 249. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 250. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 251. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 256. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 257. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 259. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 262. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 263. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 264. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 265. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 267. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 269. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 271. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 273. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 275. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 277. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 281. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 283. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 285. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 287. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 292. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 293. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 294. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 295. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 297. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 298. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 299. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 300. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 301. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 302. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 303. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 304. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 305. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 310. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 311. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2024 (USD MILLION)
  • TABLE 312. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2025-2030 (USD MILLION)
  • TABLE 313. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 315. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 316. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 317. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2024 (USD MILLION)
  • TABLE 318. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2025-2030 (USD MILLION)
  • TABLE 319. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 320. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 321. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2024 (USD MILLION)
  • TABLE 322. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025-2030 (USD MILLION)
  • TABLE 323. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-20